← Leaderboards
Tonya J. Webb
University Of Maryland Baltimore
$2,283,288
Attributed
$3,000,681
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $499.2K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,000,681 · 6
By mechanism
R21$1,460,622 · 4
T32$956,524 · 1
K01$583,535 · 1
Top collaborators
- Amanda Gail Oglesby4 shared
- Dudley K. Strickland4 shared
- Angela None Wilks4 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Priscilla A. Furth$6,008,619
- Nancy G Fossett$2,742,265
- France Carrier$2,949,818
- David Joseph Weber$22,294,951
- Richard B Alexander$2,688,058
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadImmune ResponseKiller T CellMediatingAntigensTumorMouse ModelIn VitroIn VivoSerumCell SurfaceCellsMalignant NeoplasmsT-Lymphocyte SubsetsCytokineCell CountPhenotypeCancer PatientBaseDesignImmunotherapeutic AgentMonitorLipidsAntigen-Presenting Cells
Grant awards (17)
UMB IMSD$239,900
T32 · FY2025 · GM
UMB IMSD$245,855
T32 · FY2024 · GM
UMB IMSD$237,523
T32 · FY2023 · GM
UMB IMSD$233,246
T32 · FY2022 · GM
NKT cells with chimeric antigen receptors$200,318
R21 · FY2016 · CA · contact PI
Generation of NKT cells from adult stem cells for adoptive immunotherapy$166,931
R21 · FY2016 · CA · contact PI
Generation of NKT cells from adult stem cells for adoptive immunotherapy$200,318
R21 · FY2015 · CA · contact PI
NKT cells with chimeric antigen receptors$166,931
R21 · FY2015 · CA · contact PI
Restoring NKT cell function: a novel immunotherapeutic strategy for Breast Cancer$166,931
R21 · FY2012 · CA · contact PI
Altered cellular bioenergetics influences NKT cell mediated responses to Lymphoma$163,125
R21 · FY2012 · CA · contact PI
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy$99,730
K01 · FY2012 · CA · contact PI
Restoring NKT cell function: a novel immunotherapeutic strategy for Breast Cancer$200,318
R21 · FY2011 · CA · contact PI
Altered cellular bioenergetics influences NKT cell mediated responses to Lymphoma$195,750
R21 · FY2011 · CA · contact PI
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy$103,105
K01 · FY2011 · CA · contact PI
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy$140,940
K01 · FY2010 · CA · contact PI
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy$119,880
K01 · FY2009 · CA · contact PI
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy$119,880
K01 · FY2008 · CA · contact PI